Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileLinda Michele Delahanty, M.S.

TitleAssistant Professor of Medicine
InstitutionMassachusetts General Hospital
DepartmentMedicine
AddressMassachusetts General Hospital
Suite 340, Diabetes Research
50 Staniford Street
Boston MA 02114
Phone617/724-9727
vCardDownload vCard (login for email)

Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
R18DK102737     (WEXLER, DEBORAH J)Sep 15, 2014 - Jul 31, 2019
NIH/NIDDK
REAL HEALTH-Diabetes: REach Ahead for Lifestyle and Health-Diabetes
Role: Co-Principal Investigator

M01RR001066     (SLAVIN, PETER L)Feb 1, 1978 - May 31, 2008
NIH/NCRR
General Clinical Research Center
Role: Co-Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Venditti EM, Tan K, Chang N, Laffel L, McGinley G, Miranda N, Tryggestad JB, Walders-Abramson N, Yasuda P, Delahanty L. Barriers and strategies for oral medication adherence among children and adolescents with Type 2 diabetes. Diabetes Res Clin Pract. 2018 Feb 08; 139:24-31. PMID: 29427697.
    View in: PubMed
  2. Cai J, Delahanty LM, Akapame S, Slee A, Traina S. Impact of Canagliflozin Treatment on Health-Related Quality of Life among People with Type 2 Diabetes Mellitus: A Pooled Analysis of Patient-Reported Outcomes from Randomized Controlled Trials. Patient. 2018 Jan 08. PMID: 29313267.
    View in: PubMed
  3. Houston DK, Neiberg RH, Miller ME, Hill JO, Jakicic JM, Johnson KC, Gregg EW, Hubbard VS, Pi-Sunyer X, Rejeski WJ, Wing RR, Bantle JP, Beale E, Berkowitz RI, Cassidy-Begay M, Clark JM, Coday M, Delahanty LM, Dutton G, Egan C, Foreyt JP, Greenway FL, Hazuda HP, Hergenroeder A, Horton ES, Jeffery RW, Kahn SE, Kure A, Knowler WC, Lewis CE, Martin CK, Michaels S, Montez MG, Nathan DM, Patricio J, Peters A, Pownall H, Regensteiner J, Steinburg H, Wadden TA, White K, Yanovski SZ, Zhang P, Kritchevsky SB. Physical Function Following a Long-Term Lifestyle Intervention among Middle Aged and Older Adults with Type 2 Diabetes: the Look AHEAD Study. J Gerontol A Biol Sci Med Sci. 2017 Oct 19. PMID: 29053861.
    View in: PubMed
  4. Sylvetsky AC, Edelstein SL, Walford G, Boyko EJ, Horton ES, Ibebuogu UN, Knowler WC, Montez MG, Temprosa M, Hoskin M, Rother KI, Delahanty LM. A High-Carbohydrate, High-Fiber, Low-Fat Diet Results in Weight Loss among Adults at High Risk of Type 2 Diabetes. J Nutr. 2017 11; 147(11):2060-2066. PMID: 28954840.
    View in: PubMed
  5. Ligibel JA, Barry WT, Alfano C, Hershman DL, Irwin M, Neuhouser M, Thomson CA, Delahanty L, Frank E, Spears P, Paskett ED, Hopkins J, Bernstein V, Stearns V, White J, Hahn O, Hudis C, Winer EP, Wadden TA, Goodwin PJ. Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design. NPJ Breast Cancer. 2017; 3:37. PMID: 28948213.
    View in: PubMed
  6. Delahanty LM. Weight loss in the prevention and treatment of diabetes. Prev Med. 2017 Nov; 104:120-123. PMID: 28757449.
    View in: PubMed
  7. Berkowitz RI, Marcus MD, Anderson BJ, Delahanty L, Grover N, Kriska A, Laffel L, Syme A, Venditti E, Van Buren DJ, Wilfley DE, Yasuda P, Hirst K. Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial. Pediatr Diabetes. 2018 Mar; 19(2):191-198. PMID: 28664624.
    View in: PubMed
  8. Kriska A, El Ghormli L, Copeland KC, Higgins J, Ievers-Landis CE, Levitt Katz LE, Trief PM, Wauters AD, Yasuda PM, Delahanty LM. Impact of lifestyle behavior change on glycemic control in youth with type 2 diabetes. Pediatr Diabetes. 2018 Feb; 19(1):36-44. PMID: 28378429.
    View in: PubMed
  9. McCaffery JM, Jablonski KA, Franks PW, Delahanty LM, Aroda V, Marrero D, Hamman RF, Horton ES, Dagogo-Jack S, Wylie-Rosett J, Barrett-Connor E, Kitabchi A, Knowler WC, Wing RR, Florez JC. Replication of the Association of BDNF and MC4R Variants With Dietary Intake in the Diabetes Prevention Program. Psychosom Med. 2017 Feb/Mar; 79(2):224-233. PMID: 27551991.
    View in: PubMed
  10. Trief PM, Cibula D, Delahanty LM, Weinstock RS. Self-determination theory and weight loss in a Diabetes Prevention Program translation trial. J Behav Med. 2017 Jun; 40(3):483-493. PMID: 28004335.
    View in: PubMed
  11. Delahanty LM, Riggs M, Klioze SS, Chew RD, England RD, Digenio A. Maximizing retention in long-term clinical trials of a weight loss agent: use of a dietitian support team. Obes Sci Pract. 2016 Sep; 2(3):256-265. PMID: 27708842.
    View in: PubMed
  12. Hollenbeak CS, Weinstock RS, Cibula D, Delahanty LM, Trief PM. Cost-effectiveness of SHINE: A Telephone Translation of the Diabetes Prevention Program. Health Serv Insights. 2016; 9:21-8. PMID: 27429556; PMCID: PMC4936790.
  13. Safren SA, Gonzalez JS, Wexler DJ, Psaros C, Delahanty LM, Blashill AJ, Margolina AI, Cagliero E. Erratum. A Randomized Controlled Trial of Cognitive Behavioral Therapy for Adherence and Depression (CBT-AD) in Patients With Uncontrolled Type 2 Diabetes. Diabetes Care 2014;37:625-633. Diabetes Care. 2016 06; 39(6):1065. PMID: 27222555.
    View in: PubMed
  14. Eisenstat SA, Chang Y, Porneala BC, Geagan E, Wilkins G, Chase B, O'Keefe SM, Delahanty LM, Atlas SJ, Zai AH, Finn D, Weil E, Wexler DJ. Development and Implementation of a Collaborative Team Care Model for Effective Insulin Use in an Academic Medical Center Primary Care Network. Am J Med Qual. 2017 Jul/Aug; 32(4):397-405. PMID: 27259871.
    View in: PubMed
  15. Rockette-Wagner B, Storti KL, Edelstein S, Delahanty LM, Galvin B, Jackson A, Kriska AM. Measuring Physical Activity and Sedentary Behavior in Youth with Type 2 Diabetes. Child Obes. 2017 Feb; 13(1):72-77. PMID: 26859798.
    View in: PubMed
  16. Delahanty LM. Making a Meaningful Difference: Learning From People, Practice, and Research. Diabetes Spectr. 2016 Feb; 29(1):58-64. PMID: 26912968; PMCID: PMC4755455 [Available on 02/01/17].
  17. Delahanty LM, Dalton KM, Porneala B, Chang Y, Goldman VM, Levy D, Nathan DM, Wexler DJ. Improving diabetes outcomes through lifestyle change--A randomized controlled trial. Obesity (Silver Spring). 2015 Sep; 23(9):1792-9. PMID: 26260043.
    View in: PubMed
  18. Papandonatos GD, Pan Q, Pajewski NM, Delahanty LM, Peter I, Erar B, Ahmad S, Harden M, Chen L, Fontanillas P, Wagenknecht LE, Kahn SE, Wing RR, Jablonski KA, Huggins GS, Knowler WC, Florez JC, McCaffery JM, Franks PW. Genetic Predisposition to Weight Loss and Regain With Lifestyle Intervention: Analyses From the Diabetes Prevention Program and the Look AHEAD Randomized Controlled Trials. Diabetes. 2015 Dec; 64(12):4312-21. PMID: 26253612; PMCID: PMC4657576 [Available on 12/01/16].
  19. Rockette-Wagner B, Edelstein S, Venditti EM, Reddy D, Bray GA, Carrion-Petersen ML, Dabelea D, Delahanty LM, Florez H, Franks PW, Montez MG, Rubin R, Kriska AM. The impact of lifestyle intervention on sedentary time in individuals at high risk of diabetes. Diabetologia. 2015 Jun; 58(6):1198-202. PMID: 25851102; PMCID: PMC4417075.
  20. Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Connor E, Delahanty LM, Montez MG, Ackermann RT, Zhuo X, Knowler WC, Ratner RE. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab. 2015 Apr; 100(4):1646-53. PMID: 25706240; PMCID: PMC4399293.
  21. Raynor HA, Anderson AM, Miller GD, Reeves R, Delahanty LM, Vitolins MZ, Harper P, Mobley C, Konersman K, Mayer-Davis E. Partial Meal Replacement Plan and Quality of the Diet at 1 Year: Action for Health in Diabetes (Look AHEAD) Trial. J Acad Nutr Diet. 2015 May; 115(5):731-42. PMID: 25573655.
    View in: PubMed
  22. Trief PM, Weinstock RS, Cibula D, Delahanty LM. Sustained weight loss one year after group telephone intervention: 3-year results from the SHINE study. Diabetes Res Clin Pract. 2014 Dec; 106(3):e74-8. PMID: 25451907; PMCID: PMC4262732.
  23. Trief PM, Cibula D, Delahanty LM, Weinstock RS. Depression, stress, and weight loss in individuals with metabolic syndrome in SHINE, a DPP translation study. Obesity (Silver Spring). 2014 Dec; 22(12):2532-8. PMID: 25251749; PMCID: PMC4236237.
  24. Delahanty LM, Pan Q, Jablonski KA, Aroda VR, Watson KE, Bray GA, Kahn SE, Florez JC, Perreault L, Franks PW. Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program. Diabetes Care. 2014 Oct; 37(10):2738-45. PMID: 25024396; PMCID: PMC4170126.
  25. Jaacks LM, Ma Y, Davis N, Delahanty LM, Mayer-Davis EJ, Franks PW, Brown-Friday J, Isonaga M, Kriska AM, Venditti EM, Wylie-Rosett J. Long-term changes in dietary and food intake behaviour in the Diabetes Prevention Program Outcomes Study. Diabet Med. 2014 Dec; 31(12):1631-42. PMID: 24824893; PMCID: PMC4307949.
  26. Delahanty LM. The look AHEAD study: implications for clinical practice go beyond the headlines. J Acad Nutr Diet. 2014 Apr; 114(4):537-42. PMID: 24656503.
    View in: PubMed
  27. Venditti EM, Wylie-Rosett J, Delahanty LM, Mele L, Hoskin MA, Edelstein SL. Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherence. Int J Behav Nutr Phys Act. 2014 Feb 12; 11:16. PMID: 24521153; PMCID: PMC4015875.
  28. Peter I, Papandonatos GD, Belalcazar LM, Yang Y, Erar B, Jakicic JM, Unick JL, Balasubramanyam A, Lipkin EW, Delahanty LM, Wagenknecht LE, Wing RR, McCaffery JM, Huggins GS. Genetic modifiers of cardiorespiratory fitness response to lifestyle intervention. Med Sci Sports Exerc. 2014 Feb; 46(2):302-11. PMID: 23899896; PMCID: PMC4055466.
  29. Billings LK, Jablonski KA, Ackerman RJ, Taylor A, Fanelli RR, McAteer JB, Guiducci C, Delahanty LM, Dabelea D, Kahn SE, Franks PW, Hanson RL, Maruthur NM, Shuldiner AR, Mayer-Davis EJ, Knowler WC, Florez JC. The influence of rare genetic variation in SLC30A8 on diabetes incidence and ß-cell function. J Clin Endocrinol Metab. 2014 May; 99(5):E926-30. PMID: 24471563; PMCID: PMC4010688.
  30. Franks PW, Christophi CA, Jablonski KA, Billings LK, Delahanty LM, Horton ES, Knowler WC, Florez JC. Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program. Diabetologia. 2014 Mar; 57(3):485-90. PMID: 24317794; PMCID: PMC4154629.
  31. Davis NJ, Ma Y, Delahanty LM, Hoffman HJ, Mayer-Davis E, Franks PW, Brown-Friday J, Isonaga M, Kriska AM, Venditti EM, Wylie-Rosett J. Predictors of sustained reduction in energy and fat intake in the Diabetes Prevention Program Outcomes Study intensive lifestyle intervention. J Acad Nutr Diet. 2013 Nov; 113(11):1455-64. PMID: 24144073; PMCID: PMC3962017.
  32. Safren SA, Gonzalez JS, Wexler DJ, Psaros C, Delahanty LM, Blashill AJ, Margolina AI, Cagliero E. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care. 2014; 37(3):625-33. PMID: 24170758; PMCID: PMC3931377.
  33. Maruthur NM, Ma Y, Delahanty LM, Nelson JA, Aroda V, White NH, Marrero D, Brancati FL, Clark JM. Early response to preventive strategies in the Diabetes Prevention Program. J Gen Intern Med. 2013 Dec; 28(12):1629-36. PMID: 23860722; PMCID: PMC3832727.
  34. Weinstock RS, Trief PM, Cibula D, Morin PC, Delahanty LM. Weight loss success in metabolic syndrome by telephone interventions: results from the SHINE Study. J Gen Intern Med. 2013 Dec; 28(12):1620-8. PMID: 23843020; PMCID: PMC3832730.
  35. Pan Q, Delahanty LM, Jablonski KA, Knowler WC, Kahn SE, Florez JC, Franks PW. Variation at the melanocortin 4 receptor gene and response to weight-loss interventions in the diabetes prevention program. Obesity (Silver Spring). 2013 Sep; 21(9):E520-6. PMID: 23512951; PMCID: PMC4023472.
  36. Retracted article: Common variation in PPARGC1A/B and progression to diabetes or change in metabolic traits following preventive interventions: the Diabetes Prevention Program. Diabetologia. 2013 Sep; 56(9):2102. PMID: 23616238.
    View in: PubMed
  37. Delahanty L, Kriska A, Edelstein S, Amodei N, Chadwick J, Copeland K, Galvin B, El Ghormli L, Haymond M, Kelsey MM, Lassiter C, Milaszewski K, Syme A, Mayer-Davis E. Self-reported dietary intake of youth with recent onset of type 2 diabetes: results from the TODAY study. J Acad Nutr Diet. 2013 Mar; 113(3):431-9. PMID: 23438494; PMCID: PMC3584416.
  38. Kriska A, Delahanty L, Edelstein S, Amodei N, Chadwick J, Copeland K, Galvin B, El ghormli L, Haymond M, Kelsey M, Lassiter C, Mayer-Davis E, Milaszewski K, Syme A. Sedentary behavior and physical activity in youth with recent onset of type 2 diabetes. Pediatrics. 2013 Mar; 131(3):e850-6. PMID: 23400602; PMCID: PMC3581838.
  39. Gregg EW, Chen H, Wagenknecht LE, Clark JM, Delahanty LM, Bantle J, Pownall HJ, Johnson KC, Safford MM, Kitabchi AE, Pi-Sunyer FX, Wing RR, Bertoni AG. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012 Dec 19; 308(23):2489-96. PMID: 23288372; PMCID: PMC4771522.
  40. Gonzalez JS, Schneider HE, Wexler DJ, Psaros C, Delahanty LM, Cagliero E, Safren SA. Validity of medication adherence self-reports in adults with type 2 diabetes. Diabetes Care. 2013 Apr; 36(4):831-7. PMID: 23204245; PMCID: PMC3609536.
  41. Delahanty LM, Peyrot M, Shrader PJ, Williamson DA, Meigs JB, Nathan DM. Pretreatment, psychological, and behavioral predictors of weight outcomes among lifestyle intervention participants in the Diabetes Prevention Program (DPP). Diabetes Care. 2013 Jan; 36(1):34-40. PMID: 23129133; PMCID: PMC3526204.
  42. Waxler JL, O'Brien KE, Delahanty LM, Meigs JB, Florez JC, Park ER, Pober BR, Grant RW. Genetic counseling as a tool for type 2 diabetes prevention: a genetic counseling framework for common polygenetic disorders. J Genet Couns. 2012 Oct; 21(5):684-91. PMID: 22302620; PMCID: PMC3829637.
  43. Pollin TI, Isakova T, Jablonski KA, de Bakker PI, Taylor A, McAteer J, Pan Q, Horton ES, Delahanty LM, Altshuler D, Shuldiner AR, Goldberg RB, Florez JC, Franks PW. Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program. PLoS Genet. 2012; 8(8):e1002895. PMID: 22951888; PMCID: PMC3431328.
  44. Grant RW, O'Brien KE, Waxler JL, Vassy JL, Delahanty LM, Bissett LG, Green RC, Stember KG, Guiducci C, Park ER, Florez JC, Meigs JB. Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial. Diabetes Care. 2013 Jan; 36(1):13-9. PMID: 22933432; PMCID: PMC3526219.
  45. Florez H, Pan Q, Ackermann RT, Marrero DG, Barrett-Connor E, Delahanty L, Kriska A, Saudek CD, Goldberg RB, Rubin RR. Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial. J Gen Intern Med. 2012 Dec; 27(12):1594-601. PMID: 22692637; PMCID: PMC3509296.
  46. McCaffery JM, Papandonatos GD, Peter I, Huggins GS, Raynor HA, Delahanty LM, Cheskin LJ, Balasubramanyam A, Wagenknecht LE, Wing RR. Obesity susceptibility loci and dietary intake in the Look AHEAD Trial. Am J Clin Nutr. 2012 Jun; 95(6):1477-86. PMID: 22513296; PMCID: PMC3349457.
  47. Markowitz SM, Carper MM, Gonzalez JS, Delahanty LM, Safren SA. Cognitive-behavioral therapy for the treatment of depression and adherence in patients with type 1 diabetes: pilot data and feasibility. Prim Care Companion CNS Disord. 2012; 14(2). PMID: 22943030; PMCID: PMC3425462.
  48. Vassy JL, O'Brien KE, Waxler JL, Park ER, Delahanty LM, Florez JC, Meigs JB, Grant RW. Impact of literacy and numeracy on motivation for behavior change after diabetes genetic risk testing. Med Decis Making. 2012 Jul-Aug; 32(4):606-15. PMID: 22247420; PMCID: PMC3683460.
  49. Delahanty LM, Pan Q, Jablonski KA, Watson KE, McCaffery JM, Shuldiner A, Kahn SE, Knowler WC, Florez JC, Franks PW. Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program. Diabetes Care. 2012 Feb; 35(2):363-6. PMID: 22179955; PMCID: PMC3263869.
  50. Grant RW, Meigs JB, Florez JC, Park ER, Green RC, Waxler JL, Delahanty LM, O'Brien KE. Design of a randomized trial of diabetes genetic risk testing to motivate behavior change: the Genetic Counseling/lifestyle Change (GC/LC) Study for Diabetes Prevention. Clin Trials. 2011 Oct; 8(5):609-15. PMID: 22013171; PMCID: PMC3763721.
  51. McCaffery JM, Jablonski KA, Franks PW, Dagogo-Jack S, Wing RR, Knowler WC, Delahanty L, Dabelea D, Hamman R, Shuldiner AR, Florez JC. TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program. PLoS One. 2011; 6(7):e21518. PMID: 21814547; PMCID: PMC3144193.
  52. Wadden TA, Neiberg RH, Wing RR, Clark JM, Delahanty LM, Hill JO, Krakoff J, Otto A, Ryan DH, Vitolins MZ. Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity (Silver Spring). 2011 Oct; 19(10):1987-98. PMID: 21779086; PMCID: PMC3183129.
  53. Markowitz SM, Park ER, Delahanty LM, O'Brien KE, Grant RW. Perceived impact of diabetes genetic risk testing among patients at high phenotypic risk for type 2 diabetes. Diabetes Care. 2011 Mar; 34(3):568-73. PMID: 21285385; PMCID: PMC3041182.
  54. Gonzalez JS, McCarl LA, Wexler D DD, Cagliero E, Delahanty L, Soper TD, Goldman V, Knauz R, Safren SA. Cognitive Behavioral Therapy for Adherence and Depression (CBT-AD) in Type 2 Diabetes. J Cogn Psychother. 2010 Nov 01; 24(4):329-343. PMID: 23667294.
    View in: PubMed
  55. Delahanty LM. Research charting a course for evidence-based clinical dietetic practice in diabetes. J Hum Nutr Diet. 2010 Aug; 23(4):360-70. PMID: 20456590.
    View in: PubMed
  56. Delahanty LM. An expanded role for dietitians in maximising retention in nutrition and lifestyle intervention trials: implications for clinical practice. J Hum Nutr Diet. 2010 Aug; 23(4):336-43. PMID: 20163510.
    View in: PubMed
  57. Vitolins MZ, Anderson AM, Delahanty L, Raynor H, Miller GD, Mobley C, Reeves R, Yamamoto M, Champagne C, Wing RR, Mayer-Davis E. Action for Health in Diabetes (Look AHEAD) trial: baseline evaluation of selected nutrients and food group intake. J Am Diet Assoc. 2009 Aug; 109(8):1367-75. PMID: 19631042; PMCID: PMC2804253.
  58. Delahanty LM, Nathan DM, Lachin JM, Hu FB, Cleary PA, Ziegler GK, Wylie-Rosett J, Wexler DJ. Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial. Am J Clin Nutr. 2009 Feb; 89(2):518-24. PMID: 19106241; PMCID: PMC2647518.
  59. Franks PW, Jablonski KA, Delahanty LM, McAteer JB, Kahn SE, Knowler WC, Florez JC. Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program. Diabetologia. 2008 Dec; 51(12):2214-23. PMID: 18839134; PMCID: PMC2947367.
  60. Gonzalez JS, Safren SA, Delahanty LM, Cagliero E, Wexler DJ, Meigs JB, Grant RW. Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes. Diabet Med. 2008 Sep; 25(9):1102-7. PMID: 19183315; PMCID: PMC2635490.
  61. Venditti EM, Bray GA, Carrion-Petersen ML, Delahanty LM, Edelstein SL, Hamman RF, Hoskin MA, Knowler WC, Ma Y. First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes. Int J Obes (Lond). 2008 Oct; 32(10):1537-44. PMID: 18711387; PMCID: PMC2574826.
  62. Gonzalez JS, Delahanty LM, Safren SA, Meigs JB, Grant RW. Differentiating symptoms of depression from diabetes-specific distress: relationships with self-care in type 2 diabetes. Diabetologia. 2008 Oct; 51(10):1822-5. PMID: 18690422; PMCID: PMC2678064.
  63. Delahanty LM, Nathan DM. Implications of the diabetes prevention program and Look AHEAD clinical trials for lifestyle interventions. J Am Diet Assoc. 2008 Apr; 108(4 Suppl 1):S66-72. PMID: 18358260; PMCID: PMC2726971.
  64. Raynor HA, Jeffery RW, Ruggiero AM, Clark JM, Delahanty LM. Weight loss strategies associated with BMI in overweight adults with type 2 diabetes at entry into the Look AHEAD (Action for Health in Diabetes) trial. Diabetes Care. 2008 Jul; 31(7):1299-304. PMID: 18375417; PMCID: PMC2453652.
  65. Franks PW, Jablonski KA, Delahanty L, Hanson RL, Kahn SE, Altshuler D, Knowler WC, Florez JC. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia. 2007 Dec; 50(12):2451-60. PMID: 17898990; PMCID: PMC2453532.
  66. Wylie-Rosett J, Albright AA, Apovian C, Clark NG, Delahanty L, Franz MJ, Hoogwerf B, Kulkarni K, Lichtenstein AH, Mayer-Davis E, Mooradian AD, Wheeler M. 2006-2007 American Diabetes Association Nutrition Recommendations: issues for practice translation. J Am Diet Assoc. 2007 Aug; 107(8):1296-304. PMID: 17659893.
    View in: PubMed
  67. Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E, Blais MA, Meigs JB, Grant RW. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care. 2007 Sep; 30(9):2222-7. PMID: 17536067; PMCID: PMC4440862.
  68. Delahanty LM, Grant RW, Wittenberg E, Bosch JL, Wexler DJ, Cagliero E, Meigs JB. Association of diabetes-related emotional distress with diabetes treatment in primary care patients with Type 2 diabetes. Diabet Med. 2007 Jan; 24(1):48-54. PMID: 17227324.
    View in: PubMed
  69. Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, Hoskin M, Kriska AM, Mayer-Davis EJ, Pi-Sunyer X, Regensteiner J, Venditti B, Wylie-Rosett J. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006 Sep; 29(9):2102-7. PMID: 16936160; PMCID: PMC1762038.
  70. Wadden TA, West DS, Delahanty L, Jakicic J, Rejeski J, Williamson D, Berkowitz RI, Kelley DE, Tomchee C, Hill JO, Kumanyika S. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring). 2006 May; 14(5):737-52. PMID: 16855180; PMCID: PMC2613279.
  71. Delahanty LM, Conroy MB, Nathan DM. Psychological predictors of physical activity in the diabetes prevention program. J Am Diet Assoc. 2006 May; 106(5):698-705. PMID: 16647327; PMCID: PMC2495077.
  72. Wexler DJ, Grant RW, Wittenberg E, Bosch JL, Cagliero E, Delahanty L, Blais MA, Meigs JB. Correlates of health-related quality of life in type 2 diabetes. Diabetologia. 2006 Jul; 49(7):1489-97. PMID: 16752167.
    View in: PubMed
  73. Nathan DM, Delahanty L. Your health in the 21st century. The best ways to beat diabetes. Newsweek. 2005; 145(26A):30-1. PMID: 16375138.
    View in: PubMed
  74. Delahanty LM, Nathan DM. Research navigating the course of clinical practice in diabetes. J Am Diet Assoc. 2004 Dec; 104(12):1846-53. PMID: 15565079.
    View in: PubMed
  75. Wing RR, Hamman RF, Bray GA, Delahanty L, Edelstein SL, Hill JO, Horton ES, Hoskin MA, Kriska A, Lachin J, Mayer-Davis EJ, Pi-Sunyer X, Regensteiner JG, Venditti B, Wylie-Rosett J. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res. 2004 Sep; 12(9):1426-34. PMID: 15483207; PMCID: PMC2505058.
  76. Kriska AM, Delahanty LM, Pettee KK. Lifestyle intervention for the prevention of type 2 diabetes: translation and future recommendations. Curr Diab Rep. 2004 Apr; 4(2):113-8. PMID: 15035971.
    View in: PubMed
  77. Delahanty LM, Meigs JB, Hayden D, Williamson DA, Nathan DM. Psychological and behavioral correlates of baseline BMI in the diabetes prevention program (DPP). Diabetes Care. 2002 Nov; 25(11):1992-8. PMID: 12401745; PMCID: PMC1475806.
  78. Wylie-Rosett J, Delahanty L. An integral role of the dietitian: implications of the Diabetes Prevention Program. J Am Diet Assoc. 2002 Aug; 102(8):1065-8. PMID: 12171450; PMCID: PMC2562572.
  79. Delahanty L. Winning at losing: a guide to healthy weight loss. Meal replacements. Used correctly, weight-loss shakes and bars can offer nutritious options. Diabetes Forecast. 2002 Apr; 55(4):75-6, 78. PMID: 14964151.
    View in: PubMed
  80. Delahanty LM, Hayden D, Ammerman A, Nathan DM. Medical nutrition therapy for hypercholesterolemia positively affects patient satisfaction and quality of life outcomes. Ann Behav Med. 2002; 24(4):269-78. PMID: 12434938.
    View in: PubMed
  81. Delahanty LM, Sonnenberg LM, Hayden D, Nathan DM. Clinical and cost outcomes of medical nutrition therapy for hypercholesterolemia: a controlled trial. J Am Diet Assoc. 2001 Sep; 101(9):1012-23. PMID: 11573752.
    View in: PubMed
  82. Delahanty LM. Implications of the diabetes control and complications trial for renal outcomes and medical nutrition therapy. J Ren Nutr. 1998 Apr; 8(2):59-63. PMID: 9724486.
    View in: PubMed
  83. Delahanty LM. Clinical significance of medical nutrition therapy in achieving diabetes outcomes and the importance of the process. J Am Diet Assoc. 1998 Jan; 98(1):28-30. PMID: 9434646.
    View in: PubMed
  84. Wheeler ML, Franz M, Barrier P, Holler H, Cronmiller N, Delahanty LM. Macronutrient and energy database for the 1995 Exchange Lists for Meal Planning: a rationale for clinical practice decisions. J Am Diet Assoc. 1996 Nov; 96(11):1167-71. PMID: 8906142.
    View in: PubMed
  85. Delahanty LM, Halford BN. The role of diet behaviors in achieving improved glycemic control in intensively treated patients in the Diabetes Control and Complications Trial. Diabetes Care. 1993 Nov; 16(11):1453-8. PMID: 8299434.
    View in: PubMed
  86. Anderson EJ, Richardson M, Castle G, Cercone S, Delahanty L, Lyon R, Mueller D, Snetselaar L. Nutrition interventions for intensive therapy in the Diabetes Control and Complications Trial. The DCCT Research Group. J Am Diet Assoc. 1993 Jul; 93(7):768-72. PMID: 8320402.
    View in: PubMed
  87. Delahanty L, Simkins SW, Camelon K. Expanded role of the dietitian in the Diabetes Control and Complications Trial: implications for clinical practice. The DCCT Research Group. J Am Diet Assoc. 1993 Jul; 93(7):758-64, 767. PMID: 8320401.
    View in: PubMed
  88. Delahanty L. Nutritional recommendations for cardiovascular complications of diabetes. Diabetes Educ. 1992 Nov-Dec; 18(6):543-4. PMID: 1296906.
    View in: PubMed
  89. Wheeler ML, Delahanty L, Wylie-Rosett J. Diet and exercise in noninsulin-dependent diabetes mellitus: implications for dietitians from the NIH Consensus Development Conference. J Am Diet Assoc. 1987 Apr; 87(4):480-5. PMID: 3559008.
    View in: PubMed
  90. Nathan DM, Madnek SF, Delahanty L. Programming pre-exercise snacks to prevent post-exercise hypoglycemia in intensively treated insulin-dependent diabetics. Ann Intern Med. 1985 Apr; 102(4):483-6. PMID: 3838425.
    View in: PubMed
  91. Delahanty LM. Geriatric team dynamics: the dietitian's role. J Am Diet Assoc. 1984 Nov; 84(11):1353-6. PMID: 6491115.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Delahanty's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_